肝细胞癌系统治疗的进展以及未来的前景
Rie Sugimoto1, Miho Kurokawa1, Yuki Tanaka1
1Department of Hepato-Biliary-Pancreatology, NHO Kyushu Cancer Center, 3-1-1 Notame Minami-ku, Fukuoka 811-1352, Japan.
Current oncology (Toronto, Ont.)
|September 26, 2025
概括
肝细胞癌 (HCC) 治疗现在强调系统性药物,包括免疫疗法,改善患者的治疗结果. 将药物治疗与局部治疗相结合,为HCC提供了新的治疗可能性.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 医学瘤学 医学瘤学
- 翻译研究是翻译研究.
背景情况:
- 肝细胞癌 (HCC) 治疗已经从局部疗法演变为全身药物治疗方案.
- 最近的进展包括免疫治疗和向治疗,显著改善了患者的预后.
- 系统和局部治疗的整合使得早期的治疗干预措施成为可能.
研究的目的:
- 审查目前关于肝细胞癌 (HCC) 系统性药物治疗的证据.
- 讨论不断发展的治疗策略,包括新药组合和局部治疗整合.
- 探索未来的前景,以及在HCC中需要一个可切除性分类系统的需求.
主要方法:
- 对HCC药物治疗的临床试验和证据的综合文献综述.
- 对治疗模式的分析从单一疗法转向组合疗法.
- 评估新疗法对患者结果和切除能力的影响.
主要成果:
- 系统疗法,特别是像阿特佐利祖马布和贝瓦齐祖马布这样的免疫疗法组合,显著改善了HCC患者的生存率.
- 将全身药物与局部疗法 (例如,跨动脉化学栓塞) 结合起来,可以提高治疗效率和治愈能力.
- 以前无法切除的HCC病例在全身治疗后变得容易接受手术切除.
结论:
- 通过有效的全身疗法改变了HCC治疗的格局,扩大了治疗选择.
- 未来的战略包括优化治疗组合和制定标准化的切除性标准.
- 持续的研究和临床试验对于推进HCC管理和改善患者的治疗结果至关重要.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.8K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K